Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasome Inhibitor in Poster Presentation at the 60th American Society of Hematology Annual Meeting & Exposition
Stock Information for Oncolytics Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.